Gene Editing Market Research Report- Global Forecast to 2027

Gene Editing Market Research Report, By Methods (Crispr, Talen, Zfn, Antisense Technology And Others), By Applications (Plant Genetic Engineering, Animal Genetic Engineering, Gene Therapy, Microorganisms Genetic Engineering), By End User (Biotechnology, Pharmaceutical, Contract Research Organization) – Global Forecast Till 2027

ID: MRFR/LS/0236-HCR | February 2021 | Region: Global | 80 pages

Please note that the assessment period of report has been updated from 2017–2023 to 2020-2027. Cordially fill the sample form for updated data.

Market Scenario:


Genes control heredity and provide the basic biological code to determine the specific function of cell. Cells have unique mechanism to protect themselves from attack from viruses, bacteria and fungi. Gene Editing is bimolecular method for targeted modification of DNA, including genetic materials of plants, animals and humans. In Gene Editing a DNA is inserted, deleted or replaced in the genome of an organism to treat particular diseases.


Gene Editing has been something of a revolution. It has transformed from something that is normally difficult to carry out in day to day laboratory technology. Gene Editing has generated lot of eagerness in research institutions and drug development due to its ability to change genetic mutations that may cause disease. This method helps in creating and controlling genetic information within patient cells. It is now vital in both drug discovery and diagnostics and its precision medicine that are driving growth of the market. Whereas, the restraints of the Gene Editing market is strict regulatory policies and adverse public perception related to genetic research


Figure 1- Global Gene Editing market, by methods

Gene Editing market 


Source- Annual reports, Press release, White paper, Company Presentation


 The global Gene Editing market is expected to grow at a CAGR of 18.30% during forecasted period 2019-2023.


Key Players


GenScript USA Inc. (U.S.), Horizon Discovery Group plc (U.K.), Integrated DNA Technologies, Inc. (U.S.), Lonza Group Ltd. (Switzerland), New England Biolabs, Inc. (U.S.), OriGene Technologies, Inc. (U.S.), Sangamo Biosciences, Inc. (U.S.), Sigma-Aldrich Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), and Transposagen Biopharmaceuticals, Inc. (U.S.).


Segmentation


The global Gene Editing market is segmented on basis of methods, applications and end users. Based on methods, the market is segmented as CRISPR, TALEN, ZFN, Antisense technology and others. On the basis of application they are segmented as plant genetic engineering, animal genetic engineering, microorganism’s genetic engineering and gene therapy. On the basis of end users, the market is segmented into biotechnology, pharmaceuticals and contract research organizations.    


Market Assessment


 Gene Editing Market Assessment


Sources- Annual reports, World Health Organization (WHO), White paper, Company Presentation


Regional Analysis


On the regional basis, the market is segmented into- America, Europe, Asia Pacific and Middle East and Africa. Due to huge development in drug discovery research, increase in number of research studies, development of biotechnology sector and many more are responsible for making US as dominating in market. Europe has always invested in advancement of technology for better treatment solutions. Asia Pacific has the highest growth rate for the life science market. Increasing government support to boost biotechnology sector for better treatment of diseases. Due to lack of technical knowledge, less development in biotechnology sector in Middle East & Africa will have limited growth in the market.


Study objectives global Gene Editing market



  • To provide detailed analysis of the market structure along with forecast for the next seven years of the various segments and sub-segments of the Gene Editing Market

  • To provide insights about factors affecting the market growth.

  • To analyse the Gene Editing market based on various factors- Price Analysis, Supply Chain Analysis, and Porters Five Force Analysis etc.

  • To provide past and estimated future revenue of the market’s segments and sub-segments with respect to four main geographies - America, Europe, Asia-Pacific and Middle East & Africa and their countries.

  • To provide country level analysis of the market with respect to current market size and future market growth prospect.

  • To provide country level analysis of the market’s segments which includes type and applications.

  • To provide overview of key players and their strategic profiling in the market, comprehensively analysing their core competencies and drawing a competitive landscape of the market.


Intended Audience:



  • Genome editing product manufacturers

  • Genome editing product suppliers and distributors

  • Venture capitalists

  • Regulatory bodies

  • Government research laboratories

  • Research and development (R&D) companies

  • Market research and consulting service providers

  • Medical research institutes and universities


The report for global Gene Editing market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.



Report Scope:
Report Attribute/Metric Details
  Market Size   2027: Significant Value
  CAGR   18.30% (2018-2023)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Methods, Applications and End User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   GenScript USA Inc. (U.S.), Horizon Discovery Group plc (U.K.), Integrated DNA Technologies, Inc. (U.S.), Lonza Group Ltd. (Switzerland), New England Biolabs, Inc. (U.S.), OriGene Technologies, Inc. (U.S.), Sangamo Biosciences, Inc. (U.S.), Sigma-Aldrich Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), and Transposagen Biopharmaceuticals, Inc. (U.S.)
  Key Market Opportunities   Increasing government support to boost biotechnology sector for better treatment of diseases
  Key Market Drivers

  • Huge development in drug discovery research
  • Increase in number of research studies, development of biotechnology sector


  • Frequently Asked Questions (FAQ) :


    Gene editing is a bimolecular method for targeted modification of DNA, including the genetic materials of plants, animals, and humans. In gene editing, a DNA strand is inserted, deleted, or replaced in the genome of an organism to treat particular diseases or other specific conditions.

    CRISPR holds the largest share in the Global Gene Editing Market.

    Increasing awareness about the role of genetics in the development of a number of chronic diseases is the major driver for the Gene Editing Market.

    The Americas is the leading regional market, driven by the U.S.

    Leading players in the Gene Editing Market include Lonza, Sangamo, and Sigma-Aldrich, among others.

    TABLE OF CONTENTS

    1 INTRODUCTION

    1.1 DEFINITION

    1.2 SCOPE OF STUDY

    1.2.1 RESEARCH OBJECTIVE

    1.2.2 ASSUMPTIONS & LIMITATIONS

    1.2.2.1 ASSUMPTIONS

    1.2.2.2 LIMITATIONS

    1.3 MARKET STRUCTURE

    2 RESEARCH METHODOLOGY

    2.1 RESEARCH PROCESS

    2.2 PRIMARY RESEARCH

    2.3 SECONDARY RESEARCH

    3 MARKET DYNAMICS

    3.1 DRIVERS

    3.2 RESTRAINTS

    3.3 OPPORTUNITIES

    3.4 MACROECONOMIC INDICATORS

    4 MARKET FACTOR ANALYSIS

    4.1 PORTERS FIVE FORCES MODEL

    4.2 BARGAINING POWER OF SUPPLIERS

    4.3 BARGAINING POWER OF BUYERS

    4.4 THREAT OF NEW ENTRANTS

    4.5 THREAT OF SUBSTITUTES

    4.6 INTENSITY OF RIVALRY

    5. GLOBAL GENE EDITING MARKET, BY METHODS

    5.1 CRISPR

    5.2 TALEN

    5.3 ZFN

    5.4 ANTISENSE TECHNOLOGY

    5.5 AND OTHERS

    6. GLOBAL GENE EDITING MARKET, BY APPLICATION

    6.1 ANIMAL GENETIC ENGINEERING

    6.2 PLANT GENETIC ENGINEERING

    6.3 MICROORGANISMS GENETIC ENGINEERING

    6.4 GENE THERAPY

    7. GLOBAL GENE EDITING MARKET, BY END USER

    7.1 BIOTECHNOLOGY

    7.2 PHARMACEUTICAL

    7.3 CONTRACT REAESARCH ORGANIZATION

    8. GLOBAL GENE EDITING, BY REGION

    8.1 INTRODUCTION

    8.2 AMERICA

    8.2.1 NORTH AMERICA

    8.2.1.1 US

    8.2.1.2 CANADA

    8.2.2 SOUTH AMERICA

    8.3 EUROPE

    8.3.1 WESTERN EUROPE

    8.3.1.1 GERMANY

    8.3.1.2 FRANCE

    8.3.1.3 UK

    8.3.1.4 ITALY

    8.3.1.5 SPAIN

    8.3.1.6 REST OF WESTERN EUROPE

    8.3.2 EASTERN EUROPE

    8.4 ASIA-PACIFIC

    8.4.1 JAPAN

    8.4.2 CHINA

    8.4.3 INDIA

    8.4.4 AUSTRALIA

    8.4.5 REPUBLIC OF KOREA

    8.4.6 REST OF ASIA-PACIFIC

    8.5 MIDDLE EAST & AFRICA

    8.5.1 UNITED ARAB EMIRATES

    8.5.2 SAUDI ARABIA

    8.5.3 OMAN

    8.5.4 KUWAIT

    8.5.5 QATAR

    8.5.6 REST OF MIDDLE EAST & AFRICA

    9. COMPEITIVE LANDSCAPE

    9.1 MAJOR STRATEGIES ADOPTED BY MARKET PLAYERS

    9.1.1 STRATEGIC PARTNERSHIP

    9.1.2 MERGER & ACQUISITION

    10 COMPANY PROFILE

    10.1 GENSCRIPT USA INC

    10.1.1 OVERVIEW

    10.1.2 PRODUCT OVERVIEW

    10.1.3 FINANCIALS

    10.1.4 KEY DEVELOPMENTS

    10.2 HORIZON DISCOVERY GROUP

    10.2.1 OVERVIEW

    10.2.2 PRODUCT OVERVIEW

    10.2.3 FINANCIALS

    10.2.4 KEY DEVELOPMENTS

    10.3 LONZA GROUP LTD

    10.3.1 OVERVIEW

    10.3.2 PRODUCT OVERVIEW

    10.3.3 FINANCIALS

    10.3.4 STRATEGY

    10.3.5 KEY DEVELOPMENT

    10.4 ORIGENE TECHNOLOGIES, INC.

    10.4.1 OVERVIEW

    10.4.2 PRODUCT OVERVIEW

    10.4.3 FINANCIALS

    10.4.4 KEY DEVELOPMENTS

    10.5 SIGMA-ALDRICH CORPORATION

    10.5.1 OVERVIEW

    10.5.2 PRODUCT OVERVIEW

    10.5.3 FINANCIALS

    10.5.4 KEY DEVELOPMENTS

    10.6 OTHERS

    11 CONCLUSION

    12 KEY FINDINGS

    12.1 FROM CEO’S VIEWPOINT

    12.2 UNMET NEEDS OF THE MARKET

    12.3 KEY COMPANIES TO WATCH

    12.4 PREDICTION OF GENETICS INDUSTRY

    13 APPENDIX


    LIST OF TABLES

    Table 1 Gene Editing Industry Synopsis, 2020-2027

    Table 2 Global Gene Editing Market Estimates & Forecast, 2020-2027, (USD Million)

    Table 3 Global Gene Editing Market, by Region, 2020-2027, (USD Million)

    Table 4 Global Gene Editing Market, by Methods, 2020-2027, (USD Million)

    Table 5 Global Gene Editing Market, by Application, 2020-2027, (USD Million)

    Table 6 Global Gene Editing Market, by End User, 2020-2027, (USD Million)

    Table 7 Americas Gene Editing Market, by Methods, 2020-2027, (USD Million)

    Table 8 Americas Gene Editing Market, by Application, 2020-2027, (USD Million)

    Table 9 Americas Gene Editing Market, by End User, 2020-2027, (USD Million)

    Table 10 North America Gene Editing Market, by Methods, 2020-2027, (USD Million)

    Table 11 North America Gene Editing Market, by Application, 2020-2027, (USD Million)

    Table 12 North America Gene Editing Market, by End User, 2020-2027, (USD Million)

    Table 13 South America Gene Editing Market, by Methods, 2020-2027, (USD Million)

    Table 14 South America Gene Editing Market, by Application, 2020-2027, (USD Million)

    Table 15 South America Gene Editing Market, by End User, 2020-2027, (USD Million)

    Table 16 Europe Gene Editing Market, by Methods, 2020-2027, (USD Million)

    Table 17 Europe Gene Editing Market, by Application, 2020-2027, (USD Million)

    Table 18 Europe Gene Editing Market, by End User, 2020-2027, (USD Million)

    Table 19 Western Europe Gene Editing Market by Methods, 2020-2027, (USD Million)

    Table 20 Western Europe Gene Editing Market, by Application, 2020-2027, (USD Million)

    Table 21 Western Europe Gene Editing Market, by End User, 2020-2027, (USD Million)

    Table 22 Eastern Europe Gene Editing Market, by Methods, 2020-2027, (USD Million)

    Table 23 Eastern Europe Gene Editing Market, by Application, 2020-2027, (USD Million)

    Table 24 Eastern Europe Gene Editing Market, by End User, 2020-2027, (USD Million)

    Table 25 Asia Pacific Gene Editing Market, by Methods, 2020-2027, (USD Million)

    Table 26 Asia Pacific Gene Editing Market, by Application, 2020-2027, (USD Million)

    Table 27 Asia Pacific Gene Editing Market, by End User, 2020-2027, (USD Million)

    Table 28 Middle East & Africa Gene Editing Market, by Methods, 2020-2027, (USD Million)

    Table 29 Middle East & Africa Gene Editing Market, by Application, 2020-2027, (USD Million)

    Table 30 Middle East & Africa Gene Editing Market, by End User, 2020-2027, (USD Million) 

    LIST OF FIGURES

    Figure 1 Research Process

    Figure 2 Segmentation for Global Gene Editing Market

    Figure 3 Segmentation Market Dynamics for Gene Editing Market

    Figure 4 Global Gene Editing Market Share, by Methods, 2016

    Figure 5 Global Gene Editing Market Share, by Application, 2016

    Figure 6 Global Gene Editing Market Share, by End User, 2016

    Figure 7 Global Gene Editing Market Share, by Region, 2016

    Figure 8 Americas Gene Editing Market Share, by Country, 2016

    Figure 9 Europe Gene Editing Market Share, by Country, 2016

    Figure 10 Asia Pacific Gene Editing Market Share, by Country, 2016

    Figure 11 Middle East & Africa Gene Editing Market Share, by Country, 2016

    Figure 12 Global Gene Editing Market: Company Share Analysis, 2016 (%)